Concarlo Expands Executive Leadership Team with the Appointment of Dr. Krishna Allamneni as Chief Development Officer
/PRNewswire/ -- Concarlo, a preclinical biotechnology company whose mission is to dramatically improve outcomes for patients with drug-resistant cancers by...
United States Stacy Blain Roche Genentech Krishna Allamneni Society Of Toxicology Development Officer
Source: prnewswire.com